Olomoucine ≥98%|CAS:101622-51-9|5 mg|25 mg|100 mg

2-(Hydroxyethylamino)-6-benzylamino-9-methylpurine|Olomoucine is a purine derivative that inhibits CDKs and exhibits anti-inflammatory, neuroprotective, and anticancer activities. In macrophages, olomoucine decreases levels of NO and iNOS and suppresses activation of NF- B. In leukemia cells, olomoucine alters cell cycle progression and inhibits proliferation. Additionally, this compound prevents cathepsin L translocation and the induction of autophagy in neurons, protecting against 6-OHDA-induced toxicity.|C15H18N6O|298.34||-20°C|Soluble in DMSO or methanol.